Compound ID | 139
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive, Gram-negative & Antimycobacterial |
| Mechanism of action: | DNA synthesis inhibitor |
| Target Pathogen: | Broad spectrum activity including Mycobacteria sp. |
| Description: | An isothiazoloquinolone |
| Institute where first reported: | Achillion Pharmaceuticals, USA (outsourced to Ora, Inc.) |
| Year first mentioned: | 2008 |
| Development status: | Experimental |